As previous studies reported that VHL mutant tumor cells have stronger heterogeneity or tumor neoantigen levels, we performed further investigation on the hierarchical analysis (Additional file 4: Fig. S3 and Additional file 5: Fig. S4). The gene discussed is VHL; the disease is neoplasm.